Sotera Health (SHC)
(Delayed Data from NSDQ)
$15.32 USD
+0.12 (0.79%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $15.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Sotera Health Company falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 302 | 396 | 107 | 102 | 63 |
Receivables | 153 | 131 | 113 | 114 | 99 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 48 | 37 | 54 | 34 | 37 |
Other Current Assets | 54 | 81 | 72 | 65 | 53 |
Total Current Assets | 557 | 645 | 346 | 315 | 252 |
Net Property & Equipment | 947 | 775 | 651 | 610 | 582 |
Investments & Advances | 0 | 0 | 9 | 13 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 5 | 4 | 6 | 8 | 2 |
Intangibles | 1,528 | 1,593 | 1,719 | 1,759 | 1,732 |
Deposits & Other Assets | 70 | 75 | 18 | 9 | 12 |
Total Assets | 3,130 | 3,118 | 2,790 | 2,761 | 2,581 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 71 | 74 | 73 | 52 | 42 |
Current Portion Long-Term Debt | 5 | 197 | 0 | 0 | 16 |
Current Portion Capital Leases | 9 | 2 | 1 | 1 | 1 |
Accrued Expenses | 122 | 490 | 62 | 61 | 59 |
Income Taxes Payable | 4 | 6 | 7 | 10 | 0 |
Other Current Liabilities | 13 | 15 | 9 | 7 | 6 |
Total Current Liabilities | 231 | 792 | 161 | 141 | 124 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 83 | 87 | 155 | 143 | 159 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,224 | 1,747 | 1,744 | 1,825 | 2,801 |
Non-Current Capital Leases | 64 | 57 | 41 | 35 | 30 |
Other Non-Current Liabilities | 65 | 63 | 70 | 111 | 95 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 14 | 14 |
Total Liabilities | 2,687 | 2,767 | 2,203 | 2,307 | 3,222 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 3 | 3 | 3 | 2 |
Capital Surplus | 1,215 | 1,190 | 1,173 | 1,166 | 0 |
Retained Earnings | -654 | -706 | -472 | -589 | -551 |
Other Equity | -93 | -107 | -84 | -92 | -93 |
Treasury Stock | 27 | 30 | 34 | 34 | 0 |
Total Shareholder's Equity | 444 | 350 | 586 | 455 | -641 |
Total Liabilities & Shareholder's Equity | 3,130 | 3,118 | 2,790 | 2,761 | 2,581 |
Total Common Equity | 444 | 350 | 586 | 455 | -641 |
Shares Outstanding | 282.60 | 282.10 | 282.90 | 277.40 | NA |
Book Value Per Share | 1.57 | 1.24 | 2.07 | 1.64 | 0.01 |
Fiscal Year End for Sotera Health Company falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 248 | 263 | 302 | 253 |
Receivables | NA | 135 | 119 | 153 | 145 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 58 | 51 | 48 | 38 |
Other Current Assets | NA | 57 | 54 | 54 | 84 |
Total Current Assets | NA | 498 | 487 | 557 | 520 |
Net Property & Equipment | NA | 995 | 979 | 947 | 884 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 5 | 5 | 5 | 4 |
Intangibles | NA | 1,466 | 1,493 | 1,528 | 1,530 |
Deposits & Other Assets | NA | 70 | 72 | 70 | 74 |
Total Assets | NA | 3,058 | 3,060 | 3,130 | 3,037 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 64 | 62 | 71 | 57 |
Current Portion Long-Term Debt | NA | 11 | 5 | 5 | 5 |
Current Portion Capital Leases | NA | 3 | 1 | 9 | 8 |
Accrued Expenses | NA | 69 | 62 | 122 | 106 |
Income Taxes Payable | NA | 4 | 5 | 4 | 4 |
Other Current Liabilities | NA | 13 | 13 | 13 | 13 |
Total Current Liabilities | NA | 170 | 152 | 231 | 201 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 72 | 78 | 83 | 87 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2,214 | 2,225 | 2,224 | 2,223 |
Non-Current Capital Leases | NA | 94 | 91 | 64 | 63 |
Other Non-Current Liabilities | NA | 65 | 65 | 65 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 2,635 | 2,630 | 2,687 | 2,659 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 3 | 3 | 3 | 3 |
Capital Surplus | NA | 1,229 | 1,221 | 1,215 | 1,210 |
Retained Earnings | NA | -639 | -648 | -654 | -693 |
Other Equity | NA | -145 | -120 | -93 | -114 |
Treasury Stock | NA | 25 | 26 | 27 | 28 |
Total Shareholder's Equity | NA | 423 | 429 | 444 | 377 |
Total Liabilities & Shareholder's Equity | NA | 3,058 | 3,060 | 3,130 | 3,037 |
Total Common Equity | 0 | 423 | 429 | 444 | 377 |
Shares Outstanding | 283.20 | 283.00 | 283.00 | 282.60 | 282.60 |
Book Value Per Share | 0.00 | 1.49 | 1.52 | 1.57 | 1.34 |